what drugs are considered glp 1 GLP-1 Costs Explained: Managing Coverage Challenges Mapping the effectiveness and risks

After 4 weeks, doses may be increased in 2.5 mg increments, as tolerated, up to a maximum of 15 mg once weekly

doi: 10.1056/NEJMoa2301972 [DOI] [PubMed] [Google Scholar] 206.Ji L, Jiang H, Cheng Z, et al

However, their high costs and distribution inequities underscore the need for policy interventions to enhance accessibility, particularly for underserved populations disproportionately affected by obesity

In the Heart: GLP-1 receptors were found in human and animal (mouse) cardiac tissue,In the human coronary artery endothelial cells (HCAEC) and in human umbilical vein endothelial cells (HUVEC)

Newer studies however, do not support the contention of a generalized defect in nutrient-related GLP-1 secretory responses in people with T2D, but rather suggest that the inter-individual differences in GLP-1 secretion, age of patients, duration of diabetes, concomitant drug therapy, and other variables play a role, and preclude definitive conclusions that diabetes is invariably associated with reduced GLP-1 secretion [22]